GlassScriptPhysician profile
Benjamin Carmel
NPI 1932662186
$1,788.06
in general payments reported to CMS, 2019-2025
17 companies · $327 in 2025
The $327 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $402 · 2023: $426 · 2024: $633 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,386.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $372.76 | 2022-2024 | Arikayce |
| Astrazeneca Pharmaceuticals LP | $274.29 | 2023-2024 | Breztri, Tezspire, Fasenra |
| Amgen INC. | $247.81 | 2024-2025 | Tezspire |
| Stryker Corporation | $147.35 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $136.56 | 2022 | |
| Inspire Medical Systems, INC. | $117.84 | 2023 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.54 | 2023-2025 | Ofev |
| Grifols USA, LLC | $83.33 | 2024 | Prolastin-C Liquid |
| Glaxosmithkline, LLC. | $61.72 | 2024 | Nucala |
| Jazz Pharmaceuticals INC. | $57.79 | 2022-2024 | |
| Itamar Medical INC | $44.97 | 2025 | Watchpatone |
| Takeda Pharmaceuticals U.S.A., INC. | $33.48 | 2023 | Glassia |
| Ani Pharmaceuticals, INC. | $32.95 | 2024 | Purified Cortrophin Gel |
| Viatris Specialty LLC | $32.38 | 2025 | Yupelri |
| Haemonetics Corporation | $22.10 | 2025 | Teg6s Hemostasis System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $16.76 | 2022 | |
| Pulmonx Corporation | $15.43 | 2025 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Carmel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.